Unknown

Dataset Information

0

Connexin 43 is an independent predictor of patient outcome in breast cancer patients.


ABSTRACT:

Purpose

Gap junctions are specialized membrane structures that form channels between adjacent cells allowing cell communication. Gap junctions and specifically Connexin 43 (Cx43) are down-regulated in cancer; however, there are contrasting reports on how this effects breast cancer patient survival. This paper is the first large-scale tissue microarray analysis of Cx43 expression in breast cancer patients with an associated clinical long-term follow-up.

Methods

Using a validated TMA of 1118 primary breast cancers, coupled to a comprehensive database of clinicopathological variables, the expression levels and subcellular localisation of Cx43 was assessed by immunohistochemistry. Its impact in terms of survival, distant metastasis-free survival, and clinicopathological variables was determined.

Results

Patients whose tumors expressed high levels of Cx43 had significantly better survival (p?ConclusionConnexin 43 (Cx43) is an independent predictor of breast cancer survival and distant metastasis-free survival. High expression of Cx43 was seen in only 13% of tumors, suggesting that drugs to increase Cx43 expression may result in prolonged patients survival.

SUBMITTER: Chasampalioti M 

PROVIDER: S-EPMC6418069 | biostudies-literature | 2019 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Connexin 43 is an independent predictor of patient outcome in breast cancer patients.

Chasampalioti Maria M   Green Andrew R AR   Ellis Ian O IO   Rakha Emad A EA   Jackson Andrew M AM   Spendlove Ian I   Ramage Judith M JM  

Breast cancer research and treatment 20181124 1


<h4>Purpose</h4>Gap junctions are specialized membrane structures that form channels between adjacent cells allowing cell communication. Gap junctions and specifically Connexin 43 (Cx43) are down-regulated in cancer; however, there are contrasting reports on how this effects breast cancer patient survival. This paper is the first large-scale tissue microarray analysis of Cx43 expression in breast cancer patients with an associated clinical long-term follow-up.<h4>Methods</h4>Using a validated TM  ...[more]

Similar Datasets

| S-EPMC5877554 | biostudies-literature
| S-EPMC2754227 | biostudies-literature
| S-EPMC5341190 | biostudies-literature
| S-EPMC7220876 | biostudies-literature
| S-EPMC5548912 | biostudies-literature
2009-11-30 | E-GEOD-11901 | biostudies-arrayexpress
2009-12-01 | GSE11901 | GEO
| S-EPMC2707256 | biostudies-literature
| S-ECPF-GEOD-11901 | biostudies-other
| S-EPMC5752526 | biostudies-literature